Detalhe da pesquisa
1.
Brain high-throughput multi-omics data reveal molecular heterogeneity in Alzheimer's disease.
PLoS Biol
; 22(4): e3002607, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38687811
2.
Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer's disease brains.
Alzheimers Dement
; 19(5): 1785-1799, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36251323
3.
Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures for asymptomatic and symptomatic Alzheimer's disease.
Res Sq
; 2024 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38410465
4.
Cell-free RNA signatures predict Alzheimer's disease.
iScience
; 26(12): 108534, 2023 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38089583
5.
MS4A4A modifies the risk of Alzheimer disease by regulating lipid metabolism and immune response in a unique microglia state.
medRxiv
; 2023 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36798226
6.
Examination of the Effect of Rare Variants in TREM2, ABI3, and PLCG2 in LOAD Through Multiple Phenotypes.
J Alzheimers Dis
; 77(4): 1469-1482, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32894242
7.
An atlas of cortical circular RNA expression in Alzheimer disease brains demonstrates clinical and pathological associations.
Nat Neurosci
; 22(11): 1903-1912, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31591557